Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients

MLA

Cui Li, et al. “Expression of the Immune Checkpoint Molecules CD226 and TIGIT in Preeclampsia Patients.” BMC Immunology, vol. 25, no. 1, Feb. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12865-024-00603-5.

APA

Cui Li, Haiyan Liu, & Zhongliang Duan. (2024). Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients. BMC Immunology, 25(1), 1–7. https://doi.org/10.1186/s12865-024-00603-5

Chicago

Cui Li, Haiyan Liu, and Zhongliang Duan. 2024. “Expression of the Immune Checkpoint Molecules CD226 and TIGIT in Preeclampsia Patients.” BMC Immunology 25 (1): 1–7. doi:10.1186/s12865-024-00603-5.